future glp 1 drugs Popular GLP-1 medications may have health benefits that extend beyond weight loss and blood sugar control, a new study finds Drugmakers are only months into
Description
Cost-effectivness of GLP-1 agonist use
More promising results, however, were announced the same month by Eli Lilly for its new once-daily GLP-1 pill which showed promise for weight management and for the treatment of type-2 diabetes
As a result, healthcare providers often need to adjust the dosage of diabetes medications to ensure blood sugar levels remain stable and safe
Other obesity management approaches While GLP-1 RAs have demonstrated substantial efficacy in promoting weight loss, it is useful to first examine other treatment modalities in obesity management
Novel dual incretin agent, tirzepatide (LY3298176), for the treatment of type 2 diabetes mellitus and cardiometabolic health
